Related Experiment Video
Updated: Feb 23, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Extrapulmonary effects of temporal exposure to cigarette smoke
Thais Lourenço Martins1, Keila Karine Duarte Campos1, Natália Pereira da Silva Araújo1
1Laboratory of Experimental Pathophysiology (LAFEx), Department of Biological Sciences (DECBI), Center of Research in Biological Sciences (NUPEB), Federal University of Ouro Preto (UFOP), Ouro Preto, Minas Gerais, Brazil.
Short-term cigarette smoke exposure causes inflammation and biochemical changes in mice, affecting organs beyond the lungs. These extrapulmonary effects highlight the widespread impact of smoking on the body.
Area of Science:
- Toxicology
- Pulmonary Medicine
- Biochemistry
Background:
- Cigarette smoke (CS) is known to cause significant pulmonary damage.
- Extrapulmonary effects of CS exposure are less understood.
- Investigating systemic impacts is crucial for understanding smoking-related diseases.
Purpose of the Study:
- To evaluate the extrapulmonary effects of short-term cigarette smoke exposure.
- To analyze blood components and histopathology of trachea and diaphragm muscle (DM) in mice exposed to CS.
- To identify specific biomarkers and tissue changes associated with varying durations of CS exposure.
Main Methods:
- C57BL/6 mice were exposed to CS (6 cigarettes/day) for 1 to 5 days.
- Trachea, DM, and blood were collected for morphometric and biochemical analyses.
- Comparison between a control group (CG) and CS-exposed groups (CS1D to CS5D).
Main Results:
- Increased inflammatory cell influx in DM and trachea observed in CS4D and CS5D groups.
- Elevated glycogen deposits in tracheal tissue noted in CS3D mice.
- Blood serum showed increased inflammatory cells and cholesterol in CS1D mice, elevated ALT in CS5D, elevated AST in CS3D and CS5D, and increased urea in CS5D mice.
Conclusions:
- Short-term CS exposure induces significant extrapulmonary effects in mice.
- Inflammatory and biochemical alterations occur in blood, trachea, and DM.
- Findings demonstrate systemic toxicity even with brief CS exposure.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...